Survival rates of high-risk and low-risk patients according to prediction models
| . | TTP (95% CI) . |
|---|---|
| IPI | |
| Low | 95.2 (90.7-99.9) |
| Low-intermediate | 83.1 (74.4-92.7) |
| High-intermediate | 71.2 (63.0-80.4) |
| High∗ | 70.4 (60.6-81.9) |
| MYC | |
| MYC-WT | 85.7 (81.4-90.2) |
| MYC-SH | 66.7 (50.2-88.5) |
| DH/TH | 57.4 (45.6-72.2) |
| IPI +MYC† | |
| Low | 88.4 (84.3-92.7) |
| High | 59.6 (50.7-70.1) |
| IPI+MYC+MTV | |
| Low | 84.8 (80.5-89.3) |
| High | 59.1 (48.3-72.2) |
| Radiomics | |
| Low | 86.8 (82.7-91.0) |
| High | 51.5 (40.8-65.1) |
| Radiomics +MYC | |
| Low | 87.2 (83.2-91.3) |
| High | 50.0 (39.3-63.6) |
| . | TTP (95% CI) . |
|---|---|
| IPI | |
| Low | 95.2 (90.7-99.9) |
| Low-intermediate | 83.1 (74.4-92.7) |
| High-intermediate | 71.2 (63.0-80.4) |
| High∗ | 70.4 (60.6-81.9) |
| MYC | |
| MYC-WT | 85.7 (81.4-90.2) |
| MYC-SH | 66.7 (50.2-88.5) |
| DH/TH | 57.4 (45.6-72.2) |
| IPI +MYC† | |
| Low | 88.4 (84.3-92.7) |
| High | 59.6 (50.7-70.1) |
| IPI+MYC+MTV | |
| Low | 84.8 (80.5-89.3) |
| High | 59.1 (48.3-72.2) |
| Radiomics | |
| Low | 86.8 (82.7-91.0) |
| High | 51.5 (40.8-65.1) |
| Radiomics +MYC | |
| Low | 87.2 (83.2-91.3) |
| High | 50.0 (39.3-63.6) |